Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17070995 | 0.95 | — | — | |
| SCHEMBL802107 | 0.94 | L3MBTL1 (0.35) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL31722 | 0.92 | L3MBTL1 (0.32) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL16521291 | 0.92 | MEN1 (0.35) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL19474359 | 0.92 | MEN1 (0.35) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL16521295 | 0.92 | MEN1 (0.35) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL16076439 | 0.91 | MEN1 (0.31) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL18062371 | 0.91 | RXRA (0.32) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL16076412 | 0.91 | MEN1 (0.30) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL16521268 | 0.90 | MEN1 (0.33) | L3MBTL1MEN1KMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10577355-B2 | Hetero ring compound and organic luminescent element comprising same | LG CHEM, LTD. (KR) | 2020-03-03 | — | — | US | disclosed |
| EP-3042944-B1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE | LUMINESCENCE TECH CORP (TW) | 2017-05-10 | — | — | EP | disclosed |
| WO-2016137068-A1 | HETERO RING COMPOUND AND ORGANIC LUMINESCENT ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2016-09-01 | — | — | WO | disclosed |
| EP-3042944-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE | Luminescence Technology Corp. (TW) | 2016-07-13 | — | — | EP | disclosed |
| US-9190619-B2 | Compound for organic electroluminescence device | LUMINESCENCE TECHNOLOGY CORP (TW) | 2015-11-17 | — | — | US | disclosed |
| US-9190619-B2 | Compound for organic electroluminescence device | LUMINESCENCE TECHNOLOGY CORP (TW) | 2015-11-17 | — | — | US | disclosed |
| US-20150214492-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | LUMINESCENCE TECHNOLOGY CORP (TW) | 2015-07-30 | — | — | US | disclosed |
| US-20150214492-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | LUMINESCENCE TECHNOLOGY CORP (TW) | 2015-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150214492-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLCO4C1, LEF1, SLCO2B1 | L3MBTL1 1111/4885MEN1 1422/4885KMT2A 3394/4885 |
| US-10577355-B2 | Hetero ring compound and organic luminescent element comprising same | ORC3, CRY2, GLI1 | L3MBTL1 474/4885MEN1 1020/4885KMT2A 344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.